Cross-clade HIV-1 neutralization by an antibody fragment from a lupus phage display library

AIDS

Volumn 18, Issue 2, 2004, Pages 329-331

  Karle, Sangeeta ^a   Planque, Stephanie ^a   Nishiyama, Yasuhiro ^a   Taguchi, Hiroaki ^a   Zhou, Yong Xin ^a   Salas, Maria ^b   Lake, Douglas ^c   Thiagarajan, Perumal ^a   Arnett, Frank ^a   Hanson, Carl V ^b   Paul, Sudhir ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b VIRAL AND RICKETTSIAL DISEASE LABORATORY   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTRALIZING ANTIBODY;

ANTIBODY ISOLATION; ANTIGEN BINDING; ARTICLE; BINDING AFFINITY; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; NUCLEOTIDE SEQUENCE; PHAGE DISPLAY; PRIORITY JOURNAL; PROTEIN DOMAIN; VIRUS NEUTRALIZATION;

DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; EPITOPES; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOGLOBULIN FRAGMENTS; LEUKOCYTES, MONONUCLEAR;

EID: 10744228208     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200401230-00026     Document Type: Article

References (13)

1. Kwong PD, Doyle ML, Casper DJ, Cicala C, Leavitt SA, Majeed S, et al. HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites. Nature 2002; 420:678-682.
2. Bermas BL, Petri M, Berzofsky JA, Waisman A, Shearer GM, Mozes E. Binding of glycoprotein 120 and peptides from the HIV-1 envelope by autoantibodies in mice with experimentally induced systemic lupus erythematosus and in patients with the disease. AIDS Res Hum Retroviruses 1994; 10:1071-1077.
3. Zhou YX, Karle S, Taguchi H, Planque S, Nishiyama Y, Paul S. Prospects for immunotherapeutic proteolytic antibodies. J Immunol Methods 2002; 269:257-268.
4. Olshevsky U, Helseth E, Furman C, Li J, Haseltine W, Sodroski J. Identification of individual human immunodeficiency virus type 1 gp120 amino acids important for CD4 receptor binding. J Virol 1990; 64:5701-5707.
5. Kwong PD, Wyatt R, Robinson J, Sweet RW, Sodroski J, Hendrickson WA. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature 1998; 393:648-659.
6. Palacios R, Santos J, Valdivielso P, Marquez M. Human immunodeficiency virus infection and systemic lupus erythematosus. An unusual case and a review of the literature. Lupus 2002; 11:60-63.
7. Paul S, Tramontano A, Gololobov G, Zhou YX, Taguchi H, Karle S, et al. Phosphonate ester probes for proteolytic antibodies. J Biol Chem 2001; 276:28314-28320.
8. Tyutyulkova S, Gao QS, Thompson A, Rennard A, Paul S. Efficient vasoactive intestinal polypeptide hydrolyzing autoantibody light chains selected by phage display. Biochim Biophys Acta 1996; 1316:217-223.
9. Karle S, Nishiyama Y, Zhou YX, Luo J, Planque S, Hanson C, et al. Carrier-dependent specificity of antibodies to a conserved peptide determinant of gp120. Vaccine 2003; 21:1213-1218.
10. Nossal GJ. B lymphocyte physiology: the beginning and the end. Ciba Found Symp 1997; 204:220-230.
11. D'Souza MP, Milman G, Bradac JA, McPhee D, Hanson CV, Hendry RM. Neutralization of primary HIV-1 isolates by anti-envelope monoclonal antibodies. AIDS 1995; 9:867-874.
12. Brawn RJ, Barker CR, Oesterle AD, Kelly RJ, Dandliker WB. An improved fluorescence probe cytotoxicity assay. J Immunol Methods 1975; 9:7-26.
13. Talal N, Flescher E, Dang H. Are endogenous retroviruses involved in human autoimmune disease? J Autoimmun 1992; 5 (Suppl. A):61-66.